Diagnosis and management of children with thrombosis, hemophilia and rare bleeding disorders.
Her primary areas of academic interest include quality improvement efforts to improve thrombosis risk assessment in the pediatric population, specifically elucidating the thrombosis risk in patients with sickle cell disease.
<p>Jennifer G. Davila, MD, is Co-Director, Hemophilia Treatment Center at Montefiore Einstein and Associate Professor, Pediatrics at our Albert Einstein College of Medicine. Dr. Davila focuses on the care of children with bleeding and clotting disorders.</p><p>After obtaining her Bachelor of Science in psychobiology from the State University of New York at Binghamton in 2000, Dr. Davila earned her Doctor of Medicine at Ross University School of Medicine in 2007. She completed her pediatrics internship and residency at the State University of New York Downstate Medical Center in 2010. Dr. Davila continued her medical training at Memorial Sloan Kettering Cancer Center/Weill-Cornell Medical College, completing a pediatric hematology/oncology fellowship in 2013 where she was Chief Fellow in her final year. She also completed a research fellowship at the same institution in 2014.</p><p>Dr. Davila's research focuses on thrombosis prevention in children. She has been primary investigator and co-primary investigator on funded research projects, and has shared her work through numerous peer-reviewed publications and presentations.</p><p>Dr. Davila is board certified by the American Board of Pediatrics in General Pediatrics and Pediatric Hematology Oncology. She is a member of several professional organizations, including the American Society of Hematology, the Hemostasis and Thrombosis Research Society and the American Society of Clinical Oncology, among others. She sits on the board of the American Thrombosis and Hemostasis Network, is co-chair of the Pediatric sub-committee of the Venous Thromboembolism Network of the United States and is a member of the Medical and Scientific Advisory Council of the National Bleeding Disorders Foundation.</p>